Pfizer chips in on $26M raise for rheumatoid arthritis collaborator; Hansoh licenses an anti-fungal for a mysterious infection
Two weeks after Pfizer jumped into an R&D partnership with Imcyse, the Belgian biotech reports that the pharma giant has helped contribute to a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
